Evaluation in Real World of Molecular Testing and Treatment Patterns for EGFR Mutation in Lung Cancer Patients

Clinical trial NCT03721289 · COMPLETED

Trial details

NCT number: NCT03721289
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2018-11-29
Primary completion: 2019-03-09
Enrollment: 463

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.